Cyclo Therapeutics Inc CYTH:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:02 AM EST
9.02quote price arrow up+1.12 (+14.18%)
Volume
770
Close
7.90quote price arrow up+0.44 (+5.90%)
Volume
188,447
52 week range
3.40 - 30.00

...

Loading . . .

KEY STATS

  • Open7.62
  • Day High8.50
  • Day Low7.62
  • Prev Close7.90
  • 52 Week High30.00
  • 52 Week High Date03/30/20
  • 52 Week Low3.40
  • 52 Week Low Date11/19/20
  • Market Cap36.10M
  • Shares Out4.57M
  • 10 Day Average Volume0.26M
  • Dividend-
  • Dividend Yield-
  • Beta-1.07
  • 1 Year % Change-44.37

RATIOS/PROFITABILITY

  • EPS (TTM)-6.92
  • P/E (TTM)-1.14
  • Fwd P/E (NTM)-4.03
  • EBITDA (MRQ)-8.753M
  • ROE (MRQ)-601.41%
  • Revenue (MRQ)990,000.00
  • Gross Margin (MRQ)92.67%
  • Net Margin (MRQ)-903.12%
  • Debt To Equity (MRQ)-30.22%

EVENTS

  • Earnings Date03/31/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Cyclo Therapeutics Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Cyclo Therapeutics, Inc. is a clinical stage biotechnology company. The Company develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC) and Alzheimer’s Disease. The Company’s Trappsol Cyclo, an orphan drug designated product in the United States and Europe, is the subject of three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. NPC is a fatal cholesterol metabolism disease that impacts the...
Address
6714 NW 16th Street, Suite B
Gainesville, FL
32653
United States